Swiss National Bank Incyte Corp Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Incyte Corp stock. As of the latest transaction made, Swiss National Bank holds 483,274 shares of INCY stock, worth $37.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

483,274

Previous 478,774 0.94%

Holding current value

$37.6 Million

Previous $29 Million 10.06%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $257,985 - $308,745	4,500 Added 0.94%	483,274 $31.9 Million
Q2 2024 Aug 08, 2024	SELL	$51.18 - $63.75 $4.69 Million - $5.85 Million	-91,726 Reduced 16.08%	478,774 $29 Million
Q1 2024 May 07, 2024	SELL	$56.55 - $66.59 $1.42 Million - $1.67 Million	-25,100 Reduced 4.21%	570,500 $32.5 Million
Q4 2023 Feb 06, 2024	SELL	$52.16 - $64.19 $751,104 - $924,336	-14,400 Reduced 2.36%	595,600 $37.4 Million
Q3 2023 Nov 08, 2023	SELL	$57.77 - $65.93 $4.3 Million - $4.91 Million	-74,400 Reduced 10.87%	610,000 $35.2 Million
Q2 2023 Aug 09, 2023	SELL	$60.95 - $75.51 $4.03 Million - $4.99 Million	-66,100 Reduced 8.81%	684,400 $42.6 Million
Q1 2023 May 10, 2023	SELL	$70.23 - $86.01 $1.26 Million - $1.54 Million	-17,900 Reduced 2.33%	750,500 $54.2 Million
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $3.1 Million - $3.88 Million	-46,081 Reduced 5.66%	768,400 $61.7 Million
Q3 2022 Nov 09, 2022	SELL	$66.18 - $82.86 $105,888 - $132,576	-1,600 Reduced 0.2%	814,481 $54.3 Million
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $191,922 - $241,222	2,900 Added 0.36%	816,081 $62 Million
Q1 2022 May 09, 2022	BUY	$66.02 - $79.71 $6.58 Million - $7.95 Million	99,700 Added 13.97%	813,181 $64.6 Million
Q4 2021 Feb 08, 2022	SELL	$63.34 - $74.11 $1.75 Million - $2.05 Million	-27,600 Reduced 3.72%	713,481 $52.4 Million
Q3 2021 Nov 08, 2021	SELL	$68.67 - $84.02 $1.41 Million - $1.72 Million	-20,500 Reduced 2.69%	741,081 $51 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $3.73 Million - $4.09 Million	46,749 Added 6.54%	761,581 $64.1 Million
Q1 2021 May 07, 2021	BUY	$76.02 - $100.5 $1 Million - $1.33 Million	13,200 Added 1.88%	714,832 $58.1 Million
Q4 2020 Feb 05, 2021	SELL	$80.74 - $97.7 $1.41 Million - $1.71 Million	-17,500 Reduced 2.43%	701,632 $61 Million
Q3 2020 Nov 09, 2020	SELL	$85.07 - $109.69 $825,178 - $1.06 Million	-9,700 Reduced 1.33%	719,132 $64.5 Million
Q2 2020 Aug 05, 2020	BUY	$74.18 - $108.93 $1.36 Million - $1.99 Million	18,300 Added 2.58%	728,832 $75.8 Million
Q1 2020 May 08, 2020	BUY	$63.18 - $85.97 $8.47 Million - $11.5 Million	134,100 Added 23.26%	710,532 $52 Million
Q4 2019 Feb 06, 2020	SELL	$73.04 - $95.72 $1.87 Million - $2.45 Million	-25,600 Reduced 4.25%	576,432 $50.3 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $657,710 - $781,448	9,032 Added 1.52%	602,032 $44.7 Million
Q2 2019 Aug 02, 2019	SELL	$73.52 - $88.7 $779,312 - $940,220	-10,600 Reduced 1.76%	593,000 $50.4 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $1 Million - $1.39 Million	15,800 Added 2.69%	603,600 $51.9 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $737,100 - $881,244	12,600 Added 2.19%	587,800 $37.4 Million
Q3 2018 Nov 08, 2018	SELL	$61.75 - $74.23 $1.13 Million - $1.36 Million	-18,300 Reduced 3.08%	575,200 $39.7 Million
Q2 2018 Aug 09, 2018	BUY	$60.85 - $83.98 $1.1 Million - $1.51 Million	18,000 Added 3.13%	593,500 $39.8 Million
Q1 2018 May 04, 2018	SELL	$83.06 - $100.98 $5.74 Million - $6.98 Million	-69,100 Reduced 10.72%	575,500 $48 Million
Q4 2017 Feb 07, 2018	BUY	$93.56 - $116.6 $271,324 - $338,140	2,900 Added 0.45%	644,600 $61.1 Million
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $70 Million - $88.7 Million	641,700	641,700 $74.9 Million

Others Institutions Holding INCY

# of Institutions

640

Shares Held

187M

Call Options Held

729K

Put Options Held

479K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Incyte Corp Transaction History